The Federal Joint Committee (G-BA) has set out criteria for ATMPs which are likely to require qualit...
Read moreThe first adalimumab (branded Humira) biosimilar, Amjevita, has been launched in the US by pharmaceu...
Read moreNICE has recommended the first CAR T-cell therapy, Yescarta for the treatment of some lymphomas in a...
Read moreThe economic committee for health products (CEPs) have announced a price reduction of €67 that wil...
Read moreMHRA announces UK will introduce new framework aimed at making the manufacture of innovative medicin...
Read moreNICE have recommended Enhertu for the treatment of HER2-positive breast cancer within a managed acce...
Read moreIn a phase 3 study, Crovalimab was found to be efficacious and well tolerated in people with paroxys...
Read moreBiopharmas offer significant discounts on their products in China, to try and score spots on the cou...
Read moreJapan’s largest drugmaker Takeda says it aims to seek marketing authorisation for its TAK-755 enzy...
Read moreGermany's BPI and vfa advise that the implementation of the European Health Technology Assessment (E...
Read more